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Abstract
Background: We previously developed GoMiner, an application that organizes lists of 'interesting'
genes (for example, under-and overexpressed genes from a microarray experiment) for biological
interpretation in the context of the Gene Ontology. The original version of GoMiner was oriented
toward visualization and interpretation of the results from a single microarray (or other high-
throughput experimental platform), using a graphical user interface. Although that version can be
used to examine the results from a number of microarrays one at a time, that is a rather tedious
task, and original GoMiner includes no apparatus for obtaining a global picture of results from an
experiment that consists of multiple microarrays. We wanted to provide a computational resource
that automates the analysis of multiple microarrays and then integrates the results across all of
them in useful exportable output files and visualizations.
Results: We now introduce a new tool, High-Throughput GoMiner, that has those capabilities and
a number of others: It (i) efficiently performs the computationally-intensive task of automated batch
processing of an arbitrary number of microarrays, (ii) produces a human-or computer-readable
report that rank-orders the multiple microarray results according to the number of significant GO
categories, (iii) integrates the multiple microarray results by providing organized, global clustered
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image map visualizations of the relationships of significant GO categories, (iv) provides a fast form
of 'false discovery rate' multiple comparisons calculation, and (v) provides annotations and
visualizations for relating transcription factor binding sites to genes and GO categories.
Conclusion: High-Throughput GoMiner achieves the desired goal of providing a computational
resource that automates the analysis of multiple microarrays and integrates results across all of the
microarrays. For illustration, we show an application of this new tool to the interpretation of
altered gene expression patterns in Common Variable Immune Deficiency (CVID). High-
Throughput GoMiner will be useful in a wide range of applications, including the study of time-
courses, evaluation of multiple drug treatments, comparison of multiple gene knock-outs or knock-
downs, and screening of large numbers of chemical derivatives generated from a promising lead
compound.
Background
The original version of GoMiner [1,2] was oriented
toward visualization and interpretation of the results from
a single microarray (or other high-throughput experimen-
tal platform), using a graphical user interface (GUI).
Although the GUI can be used to examine the results from
a number of microarrays one at a time, that is a rather tedi-
ous task, and there is no apparatus for obtaining a global
picture of results from an experiment that consists of mul-
tiple microarrays:
• Suppose, for example, that combinatorial chemistry
were used to generate a large number of derivatives of a
lead compound. If microarrays were used to monitor the
efficacy of those derivatives, then it is likely that none, or
at most a few, of the microarrays would be interesting. It
would be a thankless task to use the GUI to analyze and
interpret the large number of uninformative microarrays.
It would make much more sense to apply an automated
batch procedure to generate a report that highlighted the
interesting microarrays and then to examine just those in
the GUI.
• As another example, suppose that a series of microarrays
were used to generate a time-course. One would want to
obtain a high-level, global picture of the relationships of
the categories that were significant at different time points
– for instance, to differentiate phases of a disease process
or to explore the temporal sequence of events consequent
to treatment with a drug.
High-Throughput GoMiner performs those tasks. As a
tool for investigators with large sets of results, it comple-
ments and extends the GUI version's analysis and visuali-
zation capabilities. Both the command line and web
application interfaces of High-Throughput GoMiner are
freely available to all users [3]. To our knowledge, this is
the first resource that integrates information and illumi-
nates patterns from multiple microarrays in relationship
to the Gene Ontology.
In the original GoMiner article [1,2], we noted that the
Fisher's exact p-values require adjustment to account for
the multiple comparisons problem. We proposed a resa-
mpling approach that would avoid major drawbacks of
the Bonferroni correction (see, for example [4]) – the
assumption of independence of categories and the likeli-
hood of rejecting too many true positives. To provide a
more balanced solution to the problem, we have now
implemented a fast 'false discovery rate' (FDR) approach
in High-Throughput GoMiner.
Another noteworthy feature of High-Throughput GoM-
iner is the integration of transcription factor binding site
information with GO categorization and gene expression
data so that the user can explore regulatory relationships.
Although each of these types of information has been
used alone previously, our approach of integrating them
provides a powerful, novel analysis tool.
In addition to the functionality that it provides, High-
Throughput GoMiner also serves as a model for integra-
tion of the command line interface of the original GoM-
iner into other applications. The command-line interface
permits platform-independent integration of GoMiner's
functionality into any data processing stream without
modification of the GoMiner source code.
Overview of High-Throughput GoMiner
Throughout the text of this article, we will focus for con-
creteness of terminology on use of High-Throughput
GoMiner for gene expression microarrays, but the range of
application is much broader; it can be used for any high-
throughput data set in which genes or proteins are flagged
as 'interesting' for whatever reason, either as the result of
a real experiment or a 'conceptual' in silico experiment.
The program requires two kinds of input: a list of the total
set of genes on the microarray and a set of 'changed-gene'
files. Each changed-gene file contains a subset of genes
that the user considers interesting in the experiment (for
example, genes that are under-or over-expressed). TheBMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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formats of the files are the same as those required for the
original GoMiner. High-Throughput GoMiner creates two
types of output. The first is a set of reports and data files
integrating the results from all of the microarrays. The sec-
ond is a set of subdirectories, each of which contains
results files for one of the microarrays.
Two especially noteworthy features of the data processing
stream are (i) the implementation of a fast, efficient solu-
tion to the multiple testing problem (see sections on
'Computational Efficiency of High-Throughput GoMiner'
and 'The Multiple Comparisons Problem in High-
Throughput GoMiner: Estimating FDRs') and (ii) the inte-
gration of results from multiple microarrays.
There are a large number of output files. Some of them
focus on the results from a particular microarray; others
integrate the results from all of the microarrays. Both types
can be used as input to tools such as Excel or CIMminer
[5,6] to provide an integrative visualization of the results
of one or all microarrays in the study. The companion
web site [3] contains a detailed description of the input
and output files.
Significant advances relative to the original version of 
GoMiner
High-Throughput GoMiner provides significant advances
relative to the original GoMiner. Those advances are man-
ifested in both scientific value-added and usability.
Scientific value-added
1. Integration across multiple microarray experiments: CIMs
The primary scientific value-added in High-Throughput
GoMiner relative to the original GoMiner is integration of
the results across multiple related microarrays. That type
of integration is particularly useful when the set of
changed-gene files represents a time course, such as pro-
gression of a disease, response to a drug, or development
of an organism. The integration can also be useful in phar-
maceutical discovery and development – for example in
the parallel testing of many combinatorial chemistry
products against cells or organisms when microarrays are
used to provide multiplexed assay end-points. The diag-
nostics in High-Throughput GoMiner can indicate which
compounds appear to be related in their activity to which
GO categories.
Visual integration of results is achieved by producing
CIMminer [6] input files. CIMminer is our program pack-
age for computing and displaying clustered image maps
(CIMs). We introduced CIMs [5], also called clustered
'heat maps', in the mid-1990's, and they have since
become the ubiquitous summary graphic for high-
throughput 'postgenomic' data, for example from micro-
array experiments. We have extended the CIM paradigm
to permit visualization of significant GO categories inte-
grated across multiple microarrays.
2. Integration across multiple microarray experiments: 
category|gene-disease export files
Another form of integration is provided by a set of files
each of which contains a matrix whose rows are cate-
gory|changed gene pairs and whose columns are names of
changed-gene files. When the names of changed-gene files
are diseases to be compared, we refer to the output as the
'category|gene-disease' set. That set of output files is
designed for analysis by the CIMminer program package.
Clinical collaborators have found that the resulting CIMs
greatly facilitate analysis of genes with altered expression
and the interpretation of significant GO categories across
related disease phenotypes.
3. CIMs of genes with altered expression versus significant GO 
categories
High-Throughput GoMiner generates a set of files for pro-
ducing CIMs of genes with altered expression versus signif-
icant GO categories. Those CIMs facilitate determination
of the relatedness of significant GO categories as defined
by the degree of sharing of genes. The importance of that
capability can be demonstrated by two canonical
examples:
• Several GO categories can be combined into a single
cluster if they contain essentially the same set of changed
genes. Combining multiple categories in that manner
brings about a simplification since the user can think in
terms of a smaller number of clusters of related categories
rather than in terms of a larger number of individual cat-
egories. That procedure is especially important because
the parent-child structure of GO can result in a number of
statistically significant categories that may contain nearly
redundant sets of changed genes.
• Apparently unrelated GO categories might in fact be
connected by containing changed genes in common. Such
'cross talk' can often explain apparently surprising
instances in which unexpected GO categories achieve sta-
tistical significance.
4. Annotation of genes and GO categories with transcription factor 
binding site information
High-Throughput GoMiner generates automated annota-
tion of genes and GO categories with transcription factor
binding site information. For instance, one output in this
set is a file whose columns are significant GO categories
and whose rows are transcription factor binding sites for
the genes within each category. This enhancement was
motivated by the intense interest in inferring genomic reg-
ulatory networks from the results of microarray
experiments.BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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Improvements in usability
1. Automated batch processing of an arbitrary number of changed-
gene files
The original GoMiner requires a substantial number of
manual operations to analyze a changed-gene file. That
process is feasible for analysis of one or two files but
becomes tedious, time-consuming, and error-prone when
more files are to be analyzed. In a high-throughput con-
text, there may be dozens or even hundreds of files to ana-
lyze for a study. It would be virtually impossible to use the
original GoMiner to analyze that number of files. A
human operator would almost inevitably introduce errors
in the I/O, analysis, and book-keeping phases. Further-
more, in a large set of files, there may be only one or two
that produce interesting results. Manual analysis of a hun-
dred files to identify one or two files of interest would not
be cost effective. In contrast, High-Throughput GoMiner
automates both the analysis of any number of files and
the selection of those files that are likely to be worth
follow-up.
2. Automated report generation
High-Throughput GoMiner generates a report that sum-
marizes the results from all microarrays, with the best
ones – those with the largest number of significantly
enriched categories – presented at the top of a sorted list.
The user (or the computer if further downstream process-
ing is to be performed) can focus principally on the top
entries in the report.
The complete analysis process is documented and can be
reviewed if a question arises later. If the original GoMiner
had been used and a question arose about whether file
number 57 was processed correctly, or whether the results
from file number 57 were recorded correctly, many man-
ual operations would need to be repeated. In contrast,
High-Throughput GoMiner would require only a few
moments. Accurate summary reports and a well-defined
and reproducible directory structure make all of the
results immediately available. The output files and direc-
tory structure permit user-friendly access to high-level
information that characterizes all of the changed-gene
files as well as to detailed information about the results
for any particular changed-gene file. The output of High-
Throughput GoMiner is essentially self-documenting.
With the original GoMiner, manual record-keeping is a
considerable burden; the automated record-keeping in
High-Throughput GoMiner is a major asset.
3. Elimination of relatively slow access to our database server
Another important usability issue encountered by a
number of users of the original GoMiner is relatively slow
access to our database server. That issue can arise because
of the high overhead of performing successive database
accesses via the internet. The problem is not fatal, but in
practice it can limit the number of changed-gene files that
a user is able to process manually in a reasonable amount
of time. To overcome that limitation, the original GoM-
iner web site provides support for the user with IT skills
who wants to install a local version of the database.
Unfortunately, such in-house IT support may be unavail-
able to many clinicians and biologist. The web version of
High-Throughput GoMiner eliminates that problem
because it processes the web-based queries on our server
using the database that is local to our server.
Program description: procedures and files
High-Throughput GoMiner provides a choice of com-
mand line and web application interfaces. Here, we
present a brief summary of both interfaces. The command
line interface runs on Unix-based operating systems
(including Mac OS X). Complete descriptions appear at
the High-Throughput GoMiner website [3].
Both interfaces use the processing model envisioned in
our original GoMiner article [1]:
1. A statistical operation identifies a set of changed genes.
2. The set of genes is listed in the GoMiner changed-gene
file format.
3. GoMiner processes the total-and changed-gene files
using a command line interface.
4. The results are exported from GoMiner and analyzed.
5. The user is notified which changed-gene files are of
interest.
High-Throughput GoMiner generates two generic types of
output. The first pertains to integrative results for all of the
microarrays. The second pertains to each individual
microarray.
In the integrative summary report, there are three entries
for each microarray, corresponding to underexpressed,
overexpressed, and total changed genes. The entries are
sorted in descending order according to the potential
interest of the result as indicated by the number of catego-
ries that satisfy a user-defined FDR. Integrative output files
can be used to generate clustered image maps (CIMs)
[5,6] showing 'significant categories' versus 'microarrays.'
By invoking a program that identifies transcription factor
binding sites (R. Stephens, unpublished), High-Through-
put GoMiner can also generate CIMs for 'transcription fac-
tor binding sites' versus  'genes in a category' or
'transcription factor binding sites' versus 'categories in a
microarray'.BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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The web application version works with any browser. The
user uploads a total-gene file and either a single changed-
gene file or a zip file containing a set of changed-gene files.
The user receives an email containing a hyperlink to a URL
from which to download a compressed archive containing
the results.
Implementation
High-Throughput GoMiner is based on incorporation of
command line GoMiner into a set of C Shell scripts. It is
freely available and can be downloaded as a compressed
tar file for use in a Unix-based environment. The scripts
have been released under the GPL [7] open source license,
so users are welcome to edit and extend them. The utilities
used in the scripts (join, grep, gawk, sed, and curl) are
commonly available in most Unix implementations or
can be freely downloaded from sites such as the GNU
Project [8]. The program was developed and tested on Mac
OS X, Solaris, and Red Hat Linux. In our experience, there
are slight variations among operating systems, computers,
and versions of the Unix utilities. Porting between plat-
forms might require minor user intervention, such as
downloading gawk from the GNU Project rather than
using awk.
The web application version of High-Throughput GoM-
iner (Figure 1) is implemented by using a simple Java serv-
let as a wrapper around the main scripts in the command-
line version. The servlet manages the uploading of files,
sets up an individual workspace for each request, and e-
mails the user a URL for downloading results. To upload
multiple changed-gene files, the user combines them into
a single zip file. The web application version eliminates
the minor manipulations described above for the com-
mand line version. It may take longer to complete
requests because they are being executed in a shared envi-
ronment, but the user interface is much simpler. The web
version may be more suitable for the casual user who does
not have the Unix background or resources to implement
the command line version.
Computational efficiency of High-Throughput GoMiner
High-Throughput GoMiner faces two daunting computa-
tional tasks: processing an arbitrary number of microar-
rays and performing many re-sampling instances in order
to estimate the FDR. Each microarray typically requires
hundreds of instances of re-sampling, and each instance
requires the same computations as does analysis of the
real data.
To make that computational burden manageable, we have
developed a procedure that speeds up the processing time
by several orders of magnitude relative to a naïve, brute
force approach. At the heart of that procedure is the fact
that the (real) total-gene file is used as both the (concep-
tual) total-and (conceptual) changed-gene files once, and
the resulting gene-category export file is generated. The
Unix 'join' utility is then applied to that file and to the
(real) changed-gene files and re-sampled gene files in lieu
of the much more time-consuming original GUI GoMiner
process.
The multiple comparisons problem in High-Throughput 
GoMiner: estimating a false discovery rate (FDR)
Most investigators use microarray results to decide what
follow-up studies to do, rather than as definitive evidence.
The goal of the statistical analysis is to provide the experi-
menter with a good list of candidate categories for follow-
up. To decide whether or not to follow up a category that
appears enriched in changed genes, the experimenter
should know the statistical reliability of the apparent
enrichment. However, without a multiple comparisons
correction, some categories would appear enriched (have
a low p-value in the Fisher test) simply by chance. To
assess the significance of a particular category, we need to
know the distribution of p-values that would occur by
random chance. The expected number of false positives
should be some manageable percentage (for example, less
than 10%) of the categories selected. The percentage of
false positives to be tolerated will generally depend on the
relative costs of false positives and false negatives in what-
ever follow-up study is to be done. This way of framing the
question leads us to specify the false discovery rate (FDR)
for a set of categories, rather than significance level (p-
value) for each category [9]. In practice High-Throughput
GoMiner reports q-values for individual categories. The q-
value (see below) represents the smallest false discovery
rate at which that category would be classed as enriched.
For focus we will consider only 'biological_process' cate-
gories in the following discussion. Depleted categories are
of less interest to most investigators than are enriched
ones, so they will be ignored. Within a given category, the
enrichment Re is given by
Re = (nf/n)/(Nf/N)
where nf is the number of flagged genes within the partic-
ular category (i.e., genes whose expression levels are con-
sidered to be changed beyond a given threshold), n is the
total number of genes within that same category, Nf is the
number of flagged genes on the entire microarray, and N
is the total number of genes on the microarray.
The enrichment values are derived from categories of dif-
ferent sizes and do not have a common distribution. To
assess the number of false positives, we need measures
that are directly comparable. Fisher's exact p-values (for
the one-tailed test) meet this need. See the originalBMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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publication on GoMiner [1] for an extensive discussion of
the statistical and conceptual bases for choosing the
Fisher's exact test.
One way to address the multiple comparisons problem is
to associate an individual measure of reliability for an
ordered list of most enriched categories by specifying the
FDR for each. Storey et al. [9] call this a q-value. The dis-
tinction between a q-value and a Fisher's Exact p-value as
the two are used in the context of High-Throughput GoM-
iner is as follows:. The p-value, uncorrected for multiple
comparisons, is a measure of the statistical significance of
a single category. The q-value of a category is the FDR of
the list of categories whose p-values are equal to or smaller
than the p-value of that category.
To estimate the q-value for each category at each level of
significance, we use a resampling algorithm. First, we
select random samples of Nf genes at each iteration and
compute Fisher's exact test p-values for over-representa-
tion of the selected genes in all GO biological categories.
After T resamplings, the q-value for the k-th most signifi-
cant category is assessed as follows: We count the number
of times that a Fisher's exact p-value less than or equal to
the p-value, pk, of the k-th category, is found in the resam-
pled data. Then, we divide by the number of resamplings:
mk = Σi=1,...,T N(p < pk ; i)/T,
where N(p < pk ; i) refers to the number of p-values less
than pk on resampling iteration i. Finally,
Schematic of stand-alone and web versions of High-Throughput GoMiner architecture and data flow Figure 1
Schematic of stand-alone and web versions of High-Throughput GoMiner architecture and data flow.
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qk = mk/Nf.
To ask how many permutation samples are needed before
the qk values approximately reach their asymptotic values,
we performed randomization studies (see 'Stability of
Estimates of the False Discovery Rate' in Supplementary
Materials [3]; [see Additional file 1]). Those studies indi-
cate that the distribution of q-values for different catego-
ries in one resampling is usually not too different from the
distribution of q-values for one category during many
resamplings. Although T = 5000 is usual for permutation
tests on microarray data, we found that, for data sets sim-
ilar to those reported here for CVID, T = 1000 and T = 100
give essentially identical results. For any finite number of
permutation samples, there is the possibility, of course,
that one or more of the FDR estimates will be spuriously
slightly below or slightly above the selected threshold
value, but, as with ordinary p-values, slight deviations
from the threshold shouldn't be over-interpreted. A menu
in the web interface permits the user to select the appro-
priate number of resamplings. Only rarely does the order-
ing of categories by FDR differ from the ordering by
Fisher's exact p-value. Thus, even though the FDR compu-
tation is only an approximation, it does not appreciably
change which categories would have been given priority
in the absence of multiple comparisons testing.
Results
Applying High-Throughput GoMiner to gene expression 
analysis of Clinical Common Variable Immunodeficiency 
(CVID)
We now illustrate the use of high-throughput GoMiner for
interpretation of gene expression microarray data in a
medical context, that of CVID. The input [see Additional
file 2] and output [see Additional file 3] data are available
as supplementary material.
Background information on CVID
CVID is the most common symptomatic primary immun-
odeficiency disease, manifested by low levels of switched
immunoglobulin isotypes (IgG, IgA, IgE) in the serum
and by lack of humoral immune response to specific anti-
gens [10]. It is a heterogeneous disease characterized by
defects in humoral and cellular immunity [11]. The dis-
ease usually occurs in the second or third decade of life,
often heralded by recurrent pyogenic infection [12]. CVID
is associated with an increased incidence of autoimmune
disease [13,14].
High correlation of CVID and cancer
In one study, CVID patients were shown to have an 8-to
13-fold increased incidence of cancer overall, with a 438-
fold increase in lymphoma for females [15]. Another,
larger study showed an overall increased incidence of can-
cer of 1.8-fold, with the relative risks of stomach cancer
and lymphoma at 10.3-and 12.1-fold, respectively [16].
The risk for non-Hodgkin's lymphoma over the period of
25 years has been estimated to be between 1.4% and 7.0%
[17].
Using microarray technology to study global gene 
expression in CVID
Microarray technology and analysis tools have made it
possible to study global gene expression patterns in pri-
mary blood cells from CVID patients. To our knowledge
this is the first such study, and it can contribute valuable
information to what is currently known about the pathol-
ogy and pathogenesis of the disease.
Experimental methodology
Global gene expression patterns in twenty CVID patients
are currently under study in our laboratory. One patient
was selected for preliminary analysis and proof of concept
for High-Throughput GoMiner. That patient had typical
symptoms and laboratory findings, including repeated
respiratory infections and low levels of all serum
immunoglobulins.
Peripheral blood mononuclear cells (PBMC) from fresh
blood were stimulated with CD3 and CD28 for 24 hours
and used for RNA extraction. mRNA of the sample were
amplified into aRNA and coupled with Cy3 or Cy5 fluo-
rescent dye for microarray hybridization.
A detailed description of materials, methods, and data
processing is provided in the Supplementary Materials
[3]; [see Additional file 4]. An illustrative summary report
(Figure 2) and clustered image map (CIM; Figure 3) are
given in the main text (below).
High-Throughput GoMiner identifies biologically-relevant 
categories
The CIM (Figure 3) serves as a fingerprint of the patient's
molecular phenotype. The 24 genes with altered expres-
sion that caused these GO categories to be selected are
shown at the bottom, and the categories are listed along
the left-hand side. The largest category selected was
'response to external stimuli' (enrichment = 2.6-fold; p =
10-3.9; FDR = not detectable). 'Not detectable' means that
the FDR was not distinguishable from zero given the
number of randomizations used. See 'Summary Report' in
the Supplementary Materials [3] for further details [see
Additional file 6]. 'Response to external stimuli' contained
16 changed genes. All but one of those genes (DEFB1)
were also in 'immune response' (enrichment = 3.4-fold; p
= 10-5.1; FDR = not detectable). The Summary Report
shows that, of the 254 genes in this GO category, 15
exhibited significant differences in expression level when
the patient was compared with the normal controls. The
categories 'cell surface receptor linked signal transduction'BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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(enrichment = 2.7-fold; p = 10-2.1; FDR = 0.09), 'cell adhe-
sion' (enrichment = 3.3-fold; p = 10-2.1; FDR = 0.10), and
'organismal physiological process' (enrichment = 2.8-
fold; p = 10-4.3; FDR = not detectable), along with their
child categories, contained the other changed genes.
The pathology of CVID in this patient was reflected by the
GO categories with low values of FDR. CVID patients have
defects in production of specific antibodies, and those
defects may be associated with disturbed expression of
'immune/defense response genes' [18-22]. As indicated in
Figure 3 and in Summary Report, the 'immune response'
(enrichment = 3.4-fold; p = 10-5.1; FDR = not detectable),
'defense response' (enrichment = 3.2-fold; p = 10-4.8; FDR
= not detectable), and related GO categories were promi-
nent. The pathogenesis of CVID is not fully understood,
but, from other primary immune deficiency diseases, we
know that immunodeficiency may result from defects in
'antigen processing' (enrichment = 12.8-fold; p = 10-2.0;
FDR = 0.10) [23,24], 'antigen presentation exogenous
antigen' (enrichment = 12.8; p = 10-2.0; FDR = 0.10) [25],
'humoral immune responses' (enrichment = 5.4-fold; p =
10-2.7; FDR = 0.05) [26], and/or 'cell-cell signaling'
(enrichment = 4.7-fold; p = 10-2.4; FDR = 0.06) [27-29].
Altered expression of genes in those categories may affect
B cell activation, differentiation and maturation, and, ulti-
mately, immunoglobulin production in CVID [30,31].
Several forms of signal transduction, not previously asso-
ciated in the literature with CVID, were also enriched. Sig-
nal transduction plays an indispensable role in the
immune response, and we suggest that signal transduc-
tion also plays an important role in CVID [27-29]. Defec-
tive B-or T-cell signaling can cause immunodeficiency, as
can defective cytokine production or action [28,29]. Our
microarray results show that several genes related to signal
transduction (CCL2, CXCL9, EMR2, GPR56, RGS2,
TGFBR2, RGFBR3, and TGM2 in the categories 'cell sur-
face receptor linked signal transduction' (enrichment =
2.7-fold; p = 10-2.1; FDR = 0.09) and 'G-protein coupled
receptor protein signaling pathway' (enrichment = 5.1-
fold; p = 10-3.1; FDR = 0.04) are differentially expressed in
the CVID patient. Full details of the roles of these genes in
signal transduction, as well as the roles of all genes men-
tioned in this article, can be conveniently obtained via the
Screen shot of High-Throughput GoMiner results in Excel for GO categories enriched in genes with altered expression Figure 2
Screen shot of High-Throughput GoMiner results in Excel for GO categories enriched in genes with altered expression. The 
30 GO categories with FDR = 0.10 are color-coded red; the other GO categories are color-coded blue.BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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Clustered image map (CIM) [5,6] showing GO categories versus genes for genes with altered expression in a patient with  CVID Figure 3
Clustered image map (CIM) [5,6] showing GO categories versus genes for genes with altered expression in a patient with 
CVID. Yellow indicates absence of the gene from the GO category. Red and green indicate over-and underexpressed genes, 
respectively. Clustering was performed with the Pearson correlation metric and average linkage algorithm. Instructions for 
using CIMminer to generate the CIMs in this paper are given in Supplementary Materials [see Additional file 5].BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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hyperlinks to NCBI Entrez [32] in the Gene Category
Report (Supplementary Materials [3]; [see Additional file
7]).
High-Throughput GoMiner CIM facilitates grouping of 
closely-related categories into a single cluster
The 30 significant GO categories can be grouped into a
smaller number of clusters, each of which contains several
closely related categories. Grouping is desirable because it
can remove the parent-child node redundancy inherent in
the 'directed acyclic graph' (DAG) structure of GO.
Removal of that redundancy effects a modest 'dimension-
ality reduction' and simplifies interpretation of the results
vis a vis the disease phenotype. The CIM (Figure 3) of GO
categories  versus  genes was used to create a tabulation
(Table 1) of 7 clusters that result from grouping the 30 sig-
nificant GO categories.
Table 1: Clusters Of Categories Derived From The CIM (Figure 3)
Cluster Number Cluster Name Category
1 Exogenous Antigen antigen presentation exogenous antigen
antigen processing exogenous antigen via MHC class II
2 Xenobiotic xenobiotic metabolism
response to xenobiotic stimulus
3a Signaling cell surface receptor linked signal transduction
G-protein coupled receptor protein signaling pathway
4 Homeostasis calcium ion homostasis
di-tri-valent inorganic cation homeostasis
cell ion homeostasis
cation homeostasis
metal ion homeostasis
ion homeostasis
5a Response response to chemical substance
response to abiotic stimulus
3b Signaling cell-cell signaling
6 Taxis taxis
chemotaxis
5b Response cellular defense response
5c Response response to stimulus
response to external stimulus
organismal physiological process
immune response
response to biotic stimulus
defense response
5d Response response to wounding
5e Response response to pest pathogen parasite
response to stress
7 Adhesion cell adhesion
5f Response humoral immune response
humoral defense mechansimBMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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The CIM also permits detection of 'cross-talk' between GO
categories that might at first appear to be unrelated. A
number of examples can be found in Figure 3. For exam-
ple, 'G-protein coupled receptor protein signaling path-
way' and 'cell adhesion' both contain the changed genes
GPR56 and CCL2. Detailed analysis of cross-talk can
potentially provide an important systems biology inter-
pretation of the particular set of significant GO categories
in a disease state.
High-Throughput GoMiner transcription factor binding 
site CIM can help to detect genomic regulatory networks
Figure 4 indicates the richness of information available for
inference of genomic regulatory networks from a CIM for
transcription factor binding site vs. GO category. A full-
size version in which all the transcription factor binding
site names are readable is available in the Supplementary
Materials [see Additional file 8]. Among the numerous
relationships that can be mined by a systematic analysis of
this novel type of CIM is a set of transcription factors
(Table 2) that co-regulate the changed genes in the GO
category 'G-protein coupled receptor protein signaling
pathway' and a large core of 'response' categories.
A detailed discussion of differential expression of individ-
ual genes is provided in Supplementary Materials [3]; [see
Additional file 9].
Correlation of GO categories and disease phenotype
The GO categories and genes identified by High-Through-
put GoMiner are shown in Figure 3 and in Gene Category
Report. The categories and genes correlate well with the
disease's phenotype. Thus, High-Throughput GoMiner
can integrate information from entire gene expression
microarray studies into a coherent picture of biological
process gene category and disease phenotype at the
molecular level. It provides information with which
researchers can develop new hypotheses or explore poten-
tial therapeutic targets.
Applying High-Throughput GoMiner to gene expression 
analysis of schistosomiasis
To highlight how High-Throughput GoMiner can be used
to integrate time series data, we consider briefly an
example from preliminary analysis of gene expression in
schistosomiasis (Elnekave et al., in preparation). Schisto-
somiasis is associated with bladder cancer in third-world
countries [33-36]. Figure 5 shows the GO categories with
low FDR for overexpressed genes in the form of a 3-D bar
graph in Excel. Figure 6 shows a clustered image map
(CIM) generated using CIMminer [6] to show the time
course.
Discussion
Comparison of High-Throughput GoMiner with related 
programs
While this work was in progress, a number of tools for GO
analysis of microarray data have become available.
Included are EASE [41], FatiGO [42], FunSpec [43], GoS-
urfer [44,45], GO::TermFinder [46,47], Onto-Express
[48], and Ontology Traverser [49]. However, none of
them have the central integrative features that characterize
High-Throughput GoMiner. Of those tools, only GO::Ter-
mFinder permits batch processing. Since the others have
been reviewed previously and since the main features of
High-Throughput GoMiner relative to the original GoM-
iner package derive from batch processing, we will confine
the present discussion to a comparison between GO::Ter-
mFinder and High-Throughput GoMiner.
High-Throughput GoMiner appears to offer all of the
functionality of GO::TermFinder, as well as additional
important features. In an earlier section, entitled 'Signifi-
cant Advances Relative to the Original Version of GoM-
iner,' we detailed the scientific value-added and usability
features of High-Throughput GoMiner vis a vis the original
GoMiner. Those same scientific value-added and usability
features distinguish High-Throughput GoMiner from
GO::TermFinder. Because the detailed description can be
found in the above-mentioned section and technical
details can be found in the Output Files page of the High-
Throughout GoMiner web site [3], we confine ourselves
here to listing the scientific value-added and usability fea-
tures of High-Throughput GoMiner that are not present in
GO::TermFinder:
1. Integration of information across multiple microarrays
in a study: CIMs (e.g., Figure 5, 6).
2. Integration across multiple microarrays: category|gene-
disease export files.
3. CIMs of genes with altered expression versus significant
GO categories (Figure 3).
4. Annotation of genes and GO categories with transcrip-
tion factor binding site information (Figure 4).
5. Prioritization of microarrays in a study on the basis of
the number of categories that are statistically significantly
enriched.
There are also a number of usability features that distin-
guish High-Throughput GoMiner from GO::TermFinder:
6. Greater simplicity in the running of High-Throughput
GoMiner. The GO::TermFinder batch processing feature
[50] is implemented through the 'analyze.pl' module. TheBMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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Clustered image map (CIM) [5,6] showing transcription factor binding sites versus GO categories in a patient with CVID Figure 4
Clustered image map (CIM) 5,6 showing transcription factor binding sites versus GO categories in a patient with CVID. Red 
indicate FDR = 0.0, and yellow indicates FDR > 1.0 or a missing value. Clustering was performed with the Pearson correlation 
metric and average linkage algorithm. The inset is a blow-up of the first few transcription factor binding site names. A full-size 
version in which all the transcription factor binding site names are readable is available in Supplementary Materials [see Addi-
tional file 8]. There are 35 rather than 30 GO categories because this result was computed with a more recent version of the 
GO Consortium database.BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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implementation requires that the user supply both an
annotation file and an ontology file, obtained from the
GO Consortium web site. In contrast, High-Throughput
GoMiner accesses the annotation and ontology informa-
tion through a database that we maintain on our server, so
the low-level implementation details are transparent to
the user.
7. Greater generalization of annotations in High-
Throughput GoMiner. The default mode of High-
Throughput GoMiner includes all annotations in the GO
Consortium database, with the option to restrict the
annotations to any arbitrary combination of annotation
sources.
8. Greater control over species selection for High-
Throughput GoMiner. The default mode of High-
Throughput GoMiner permits restricting the query to any
single species (e.g., mouse or human) or to any
combination of species represented within the GO Con-
sortium database. That is a functionally important type of
flexibility.
9. Recognition of HUGO gene names by High-Through-
put GoMiner. The High-Throughput GoMiner database
can recognize HUGO names as well as any of the other
identifier types provided by the GO Consortium database.
The ability to recognize HUGO names is not an inherent
feature of the annotation provided by the GO
Consortium, so users of GO::TermFinder are not able to
access HUGO names in their queries.
10. Platform-independence of the Web Interface Version
of High-Throughput GoMiner. The Web Interface Version
of High-Throughput GoMiner is platform-independent
because it is a web server application. In contrast, a Unix
environment is required to use the batch processing capa-
bility of GO::TermFinder [51].
11. Output formatting differs between High-Throughput
GoMiner and GO::TermFinder. The latter appears to
present output in a list format, whereas several modes of
output (at the level of either individual microarray or inte-
gration of all microarrays) are available with High-
Throughput GoMiner.
In summary, of the tools available for using GO to inter-
pret microarray (or analogous) data, only GO::Ter-
mFinder and High-Throughput GoMiner offer batch-
processing capability. GoMiner, in addition, provides
tools and visualizations for integrating information from
the batch of microarrays and for relating them to
transcription factor binding sites and regulatory networks.
Because of additional scientific and usability
characteristics of High-Throughput GoMiner, it is particu-
larly well suited to the needs of the molecular biology,
genomics, and proteomics communities.
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Conclusion
High-Throughput GoMiner efficiently performs the com-
putationally challenging task of automated batch-process-
ing of an arbitrary number of microarrays (or other
conceptually similar sets of large data sets). To our
knowledge, it is the first resource for integration of high-
throughput analyses of multiple microarrays. The auto-
Table 2: Names and Consensus Sequences for Transcription 
Factors that Co-Regulate the Changed Genes in the GO 
Category 'G-protein Coupled Receptor Protein Signaling 
Pathway' and a Large Core of 'Response' Categories (Figure 4 
and Supplementary Materials [see Additional file 8])
Name Consensus
AP-1-IL-3 TGAGTCA
AP-1-involucrin-H2 TGCCTCA
ASP-CYP21 CTCTGTGG
AlphaCE2Maf-Bfsp1 TGCTGAC
B2_RS TCCTATCA
CP2-consensus GCNMNANCMAG
CPSI-B1 TCTCCCA
EBF/Olf-1_site_2 TCCCNNRRGRR
EBV-ZRE2 TGAGCAA
FHX-type-A-CS WMARYAAAYA
GAGA_box/CT_element AGAGARRRR
GH-CSE2 AATAAAT
GRE_CS7 WCTGWTCT
GRE_CS8 AGAWCAGW
GT-2B_RS CCAGCTG
GT-IIBa-SV40 ACAGCTG
HNF5-erk1 TATTTGT
HiNF-Ahist AGAAATG
IL4-P0/P1 ATTTTCC
Initiator_CS CTCANTCT
MEF-2-consensus YTWWAAATAR
MEF-2_CS YTAWAAATAR
NF-Y-consensus BVDCCAATVVVVD
PuF_RS GGGTGGG
RadLV-core TGTGGTCA
Runx_CS AACCACA
Six5_CS TCARRTTNC
Sp1-VGF_1 AGGGAGG
TCF-2-alpha_CS SAGGAAGY
TCR-beta-site-6 AATACAA
TRE.1 TGACTCA
c-Myc_RS1 TCTCTTA
c-mos_DS3 GTTTTAA
delta-rpL7 GGAGGCTG
forkhead_CS WAARYAAAYW
p300-consensus GGGAGTGBMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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matically generated output files permit visualization of
time series data in a 3-D bar chart in Excel or as a hierar-
chically clustered image map (CIM) of the interesting GO
categories in relation to expression (or transcription factor
binding sites).
As a proof of concept, we used High-Throughput GoMiner
to analyze the results of a microarray study of differences
in gene expression between a patient with CVID and nor-
mal controls. Because the phenotypes of immunodefi-
ciency diseases have been well described, we were able to
demonstrate that the GO categories found by High-
Throughput GoMiner were those that were expected (e.g.,
Time series for GO categories with low FDR for overexpressed genes Figure 5
Time series for GO categories with low FDR for overexpressed genes. The data were obtained from a study of schistosomiasis 
in a murine model [37-40] over the course of 20 weeks after infection. 3D bar graph visualization in Excel. (Elnekave et al, in 
preparation).BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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'immune response'). Since this was the first global gene
expression study of CVID, the analyses using High-
Throughput GoMiner have provided new information on
biological process categories and specific genes in the dis-
ease. For example, most of the differentially expressed
genes were found in signal transduction categories. Signal
transduction had not previously been reported to play a
role in CVID. High-Throughput GoMiner thus has the
potential to generate new biomedical hypotheses and
identify new targets for research.
We have tried to make High-Throughput GoMiner as flex-
ible as possible by providing both command line and web
server versions. The command line version provides faster
calculation and the potential for highly parallel process-
ing; the web server version provides transparency and ease
of use. The next phases of genomics and proteomics will
CIM [5,6] with hierarchically clustered categories (Pearson correlation, average linkage clustering) versus time (Elnekave et al.,  in preparation). Figure 6
CIM [5,6] with hierarchically clustered categories (Pearson correlation, average linkage clustering) versus time (Elnekave et al., 
in preparation).BMC Bioinformatics 2005, 6:168 http://www.biomedcentral.com/1471-2105/6/168
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impose increasing demands for flexible, large-scale, auto-
mated information processing. We see High-Throughput
GoMiner as a key resource for addressing that challenge.
Availability and requirements
Project name: High-Throughput GoMiner; Project home
page: http://discover.nci.nih.gov/gominer/htgm.jsp;
Operating system(s): web version is platform independ-
ent, command line version requires Unix; Programming
language: java and Unix C shell; Other requirements:
detailed on web site and on documentation packaged in
command line version download; License: GNU GPL;
Restrictions to use by non-academics: none.
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